US Stock MarketDetailed Quotes

LEGN Legend Biotech

Watchlist

45.410
-0.520-1.13%

Close May 3 16:00 ET

45.420
+0.010+0.02%

Post 17:00 ET

8.26BMarket Cap-15445P/E (TTM)

Legend Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-95.39%-393.28M

-92.28%-95.65M

15.62%-60.85M

-163.86%-124.81M

-248.54%-111.97M

-1.42%-201.28M

28.48%-49.74M

-61.71%-72.11M

-47.3M

-32.13M

Net income from continuing operations

-16.69%-520.12M

-8.17%-146.81M

26.31%-62.5M

-2.99%-198.84M

-248.54%-111.97M

-9.46%-445.72M

-24.15%-135.72M

32.37%-84.8M

-147.91%-193.07M

66.04%-32.13M

Operating gains losses

1,114.21%114.2M

299.20%38.36M

72.23%-17.07M

----

-193.51%-11.26M

133.07%9.61M

-262.40%-61.49M

----

Depreciation and amortization

11.20%20.45M

1.94%5.35M

1.19%5.17M

----

32.15%18.39M

41.44%5.25M

46.08%5.11M

----

Other non cash items

-492.34%-33.3M

-2,525.11%-11.6M

-507.22%-12.87M

-61.30%20.25M

37.54%-29.08M

3,067.48%8.49M

-525.00%-442K

1,780.85%3.16M

176.94%52.33M

-168.66%-46.56M

Change In working capital

-139.41%-71.34M

-121.48%-11.59M

-103.26%-1.79M

----

11.86%181.03M

-8.44%53.98M

68.85%54.96M

----

-Change in receivables

-296.70%-98.98M

-319,416.13%-99.05M

3,633.00%15.04M

----

104.64%50.32M

99.94%-31K

-97.01%403K

----

-Change in inventory

8.54%-12.71M

3.20%-5.05M

-24.09%-2.82M

----

-27,341.18%-13.89M

-4,433.04%-5.21M

-3,254.17%-2.27M

----

-Change in prepaid assets

82.76%-8.72M

-118.01%-2.31M

100.31%101K

----

-1,606.47%-50.61M

1,759.71%12.83M

-1,160.39%-32.46M

----

-Change in payables and accrued expense

-126.87%-51.51M

-116.04%-7.01M

-114.51%-12.89M

----

34.50%191.73M

-39.66%43.69M

141.91%88.87M

----

-Change in other current assets

-79.43%753K

-72.78%753K

--0

----

411.57%3.66M

581.04%2.77M

44.87%452K

----

-Change in other current liabilities

-7.98%-176K

2,702.44%1.07M

-2,972.50%-1.23M

----

-3.16%-163K

93.11%-41K

---40K

----

-Change in other working capital

666,766.67%100M

----

98.58%-15K

----

Cash from discontinued investing activities

Operating cash flow

-95.39%-393.28M

-92.28%-95.65M

15.62%-60.85M

-12,836.49%-95.73M

-79.26%-141.05M

-1.42%-201.28M

28.48%-49.74M

-61.71%-72.11M

98.71%-740K

-193.75%-78.69M

Investing cash flow

Cash flow from continuing investing activities

220.36%92.79M

1,534.48%407.51M

-263.48%-209.07M

60.46%-77.09M

-74.17%24.93M

221.03%127.89M

Net PPE purchase and sale

4.03%-20.08M

33.69%-4.35M

-108.17%-5.38M

----

50.40%-20.93M

-261.64%-6.55M

77.49%-2.58M

----

Net intangibles purchase and sale

-95.70%-2.64M

-158.41%-2.5M

-110.51%-96K

----

57.97%-1.35M

-378.45%-969K

180.73%913K

----

Net investment purchase and sale

631.97%213.39M

1,012.58%432.94M

-235.73%-177.32M

----

72.87%-40.11M

-60.96%38.91M

240.37%130.64M

----

Net other investing changes

-565.60%-97.88M

-187.68%-18.58M

-2,333.15%-26.28M

----

-760.95%-14.71M

---6.46M

---1.08M

----

Cash from discontinued investing activities

Investing cash flow

220.36%92.79M

1,534.48%407.51M

-263.48%-209.07M

-4,880.70%-123.58M

107.71%17.93M

60.46%-77.09M

-74.17%24.93M

221.03%127.89M

101.53%2.59M

-1,255.69%-232.5M

Financing cash flow

Cash flow from continuing financing activities

109.40%791.49M

218.14%925K

-99.75%961K

-39.68%377.98M

-100.24%-783K

32,946.81%377.73M

Net issuance payments of debt

-44.65%-3.76M

121.61%304K

-144.81%-1.72M

----

-82.95%-2.6M

-233.41%-1.41M

-57.27%-703K

----

Net common stock issuance

54.56%583.69M

--0

----

-39.43%377.64M

--0

--377.64M

----

Proceeds from stock option exercised by employees

7,122.84%211.56M

-0.48%621K

241.66%2.68M

----

-36.90%2.93M

14.92%624K

-50.63%785K

----

Cash from discontinued financing activities

Financing cash flow

109.40%791.49M

218.14%925K

-99.75%961K

78,184.44%789.89M

-1,244.00%-286K

-39.68%377.98M

-100.24%-783K

32,946.81%377.73M

-99.67%1.01M

-87.92%25K

Net cash flow

Beginning cash position

14.09%786.03M

18.55%963.47M

224.72%1.23B

74.72%660.05M

14.09%786.03M

51.19%688.94M

140.22%812.73M

-22.21%379.78M

-8.37%377.79M

51.19%688.94M

Current changes in cash

392.96%491M

1,322.17%312.79M

-162.04%-268.96M

19,892.26%570.58M

60.34%-123.41M

-57.29%99.6M

-107.30%-25.59M

390.70%433.5M

-96.22%2.85M

-611.55%-311.16M

Effect of exchange rate changes

127.17%682K

231.11%1.45M

-43.33%-784K

399.07%2.58M

-25,820.00%-2.57M

-7,482.35%-2.51M

-1,521.79%-1.11M

27.93%-547K

-328.57%-864K

-97.03%10K

End cash Position

62.55%1.28B

18.55%963.47M

224.72%1.23B

74.72%660.05M

14.09%786.03M

140.22%812.73M

-22.21%379.78M

-8.37%377.79M

Free cash flow

-86.08%-416M

-78.99%-102.49M

10.11%-66.32M

-667.50%-106.13M

-79.26%-141.05M

8.33%-223.56M

19.33%-57.26M

-28.97%-73.78M

84.44%-13.83M

-193.75%-78.69M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-95.39%-393.28M	-92.28%-95.65M	15.62%-60.85M	-163.86%-124.81M	-248.54%-111.97M	-1.42%-201.28M	28.48%-49.74M	-61.71%-72.11M	-47.3M	-32.13M
Net income from continuing operations	-16.69%-520.12M	-8.17%-146.81M	26.31%-62.5M	-2.99%-198.84M	-248.54%-111.97M	-9.46%-445.72M	-24.15%-135.72M	32.37%-84.8M	-147.91%-193.07M	66.04%-32.13M
Operating gains losses	1,114.21%114.2M	299.20%38.36M	72.23%-17.07M	----	----	-193.51%-11.26M	133.07%9.61M	-262.40%-61.49M	----	----
Depreciation and amortization	11.20%20.45M	1.94%5.35M	1.19%5.17M	----	----	32.15%18.39M	41.44%5.25M	46.08%5.11M	----	----
Other non cash items	-492.34%-33.3M	-2,525.11%-11.6M	-507.22%-12.87M	-61.30%20.25M	37.54%-29.08M	3,067.48%8.49M	-525.00%-442K	1,780.85%3.16M	176.94%52.33M	-168.66%-46.56M
Change In working capital	-139.41%-71.34M	-121.48%-11.59M	-103.26%-1.79M	----	----	11.86%181.03M	-8.44%53.98M	68.85%54.96M	----	----
-Change in receivables	-296.70%-98.98M	-319,416.13%-99.05M	3,633.00%15.04M	----	----	104.64%50.32M	99.94%-31K	-97.01%403K	----	----
-Change in inventory	8.54%-12.71M	3.20%-5.05M	-24.09%-2.82M	----	----	-27,341.18%-13.89M	-4,433.04%-5.21M	-3,254.17%-2.27M	----	----
-Change in prepaid assets	82.76%-8.72M	-118.01%-2.31M	100.31%101K	----	----	-1,606.47%-50.61M	1,759.71%12.83M	-1,160.39%-32.46M	----	----
-Change in payables and accrued expense	-126.87%-51.51M	-116.04%-7.01M	-114.51%-12.89M	----	----	34.50%191.73M	-39.66%43.69M	141.91%88.87M	----	----
-Change in other current assets	-79.43%753K	-72.78%753K	--0	----	----	411.57%3.66M	581.04%2.77M	44.87%452K	----	----
-Change in other current liabilities	-7.98%-176K	2,702.44%1.07M	-2,972.50%-1.23M	----	----	-3.16%-163K	93.11%-41K	---40K	----	----
-Change in other working capital	666,766.67%100M	----	----	----	----	98.58%-15K	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-95.39%-393.28M	-92.28%-95.65M	15.62%-60.85M	-12,836.49%-95.73M	-79.26%-141.05M	-1.42%-201.28M	28.48%-49.74M	-61.71%-72.11M	98.71%-740K	-193.75%-78.69M
Investing cash flow
Cash flow from continuing investing activities	220.36%92.79M	1,534.48%407.51M	-263.48%-209.07M			60.46%-77.09M	-74.17%24.93M	221.03%127.89M
Net PPE purchase and sale	4.03%-20.08M	33.69%-4.35M	-108.17%-5.38M	----	----	50.40%-20.93M	-261.64%-6.55M	77.49%-2.58M	----	----
Net intangibles purchase and sale	-95.70%-2.64M	-158.41%-2.5M	-110.51%-96K	----	----	57.97%-1.35M	-378.45%-969K	180.73%913K	----	----
Net investment purchase and sale	631.97%213.39M	1,012.58%432.94M	-235.73%-177.32M	----	----	72.87%-40.11M	-60.96%38.91M	240.37%130.64M	----	----
Net other investing changes	-565.60%-97.88M	-187.68%-18.58M	-2,333.15%-26.28M	----	----	-760.95%-14.71M	---6.46M	---1.08M	----	----
Cash from discontinued investing activities
Investing cash flow	220.36%92.79M	1,534.48%407.51M	-263.48%-209.07M	-4,880.70%-123.58M	107.71%17.93M	60.46%-77.09M	-74.17%24.93M	221.03%127.89M	101.53%2.59M	-1,255.69%-232.5M
Financing cash flow
Cash flow from continuing financing activities	109.40%791.49M	218.14%925K	-99.75%961K			-39.68%377.98M	-100.24%-783K	32,946.81%377.73M
Net issuance payments of debt	-44.65%-3.76M	121.61%304K	-144.81%-1.72M	----	----	-82.95%-2.6M	-233.41%-1.41M	-57.27%-703K	----	----
Net common stock issuance	54.56%583.69M	--0	--0	----	----	-39.43%377.64M	--0	--377.64M	----	----
Proceeds from stock option exercised by employees	7,122.84%211.56M	-0.48%621K	241.66%2.68M	----	----	-36.90%2.93M	14.92%624K	-50.63%785K	----	----
Cash from discontinued financing activities
Financing cash flow	109.40%791.49M	218.14%925K	-99.75%961K	78,184.44%789.89M	-1,244.00%-286K	-39.68%377.98M	-100.24%-783K	32,946.81%377.73M	-99.67%1.01M	-87.92%25K
Net cash flow
Beginning cash position	14.09%786.03M	18.55%963.47M	224.72%1.23B	74.72%660.05M	14.09%786.03M	51.19%688.94M	140.22%812.73M	-22.21%379.78M	-8.37%377.79M	51.19%688.94M
Current changes in cash	392.96%491M	1,322.17%312.79M	-162.04%-268.96M	19,892.26%570.58M	60.34%-123.41M	-57.29%99.6M	-107.30%-25.59M	390.70%433.5M	-96.22%2.85M	-611.55%-311.16M
Effect of exchange rate changes	127.17%682K	231.11%1.45M	-43.33%-784K	399.07%2.58M	-25,820.00%-2.57M	-7,482.35%-2.51M	-1,521.79%-1.11M	27.93%-547K	-328.57%-864K	-97.03%10K
End cash Position	62.55%1.28B	62.55%1.28B	18.55%963.47M	224.72%1.23B	74.72%660.05M	14.09%786.03M	14.09%786.03M	140.22%812.73M	-22.21%379.78M	-8.37%377.79M
Free cash flow	-86.08%-416M	-78.99%-102.49M	10.11%-66.32M	-667.50%-106.13M	-79.26%-141.05M	8.33%-223.56M	19.33%-57.26M	-28.97%-73.78M	84.44%-13.83M	-193.75%-78.69M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall